-
Moderna calls itself the “true innovator” in response to CureVac mRNA patent lawsuit, cites broken non-assert promise
Read more: Moderna calls itself the “true innovator” in response to CureVac mRNA patent lawsuit, cites broken non-assert promiseModerna has filed a response to CureVac’s mRNA patent suit, denying infringement, attacking the validity of all 10 patents, and calling the lawsuit “ultimately a meritless attempt to claim success for work it never did”.
-
Maxell notches partial USITC win against Samsung as Galaxy import ban recommended
Read more: Maxell notches partial USITC win against Samsung as Galaxy import ban recommendedIt’s just one part of a multi-theater battle between the two Asian companies which has seen Maxell awarded, and subsequently stripped of, $112 million in damages.
-
Wendy’s, Gap, and other merchants hit in Texas PAE campaign asserting ex-Cypress Semiconductor patents
Read more: Wendy’s, Gap, and other merchants hit in Texas PAE campaign asserting ex-Cypress Semiconductor patentsNear Field Electronics is targeting digital payments at a time when point-of-sale devices are becoming a patent hotspot.
-
Viasat prevails in $229M jury verdict against Japanese rival over NAND patent infringement
Read more: Viasat prevails in $229M jury verdict against Japanese rival over NAND patent infringementThe U.S. District Court for the Western District of Texas has ruled that Kioxia owes Viasat $229 million for infringing one of its flash-memory patents.
-
Awaiting potential $1.3B Moderna payout, Arbutus expands Covid-19 patent fight to Pfizer, BioNTech in Canada and UPC
Read more: Awaiting potential $1.3B Moderna payout, Arbutus expands Covid-19 patent fight to Pfizer, BioNTech in Canada and UPCArbutus and Genevant have filed new lawsuits against Pfizer and BioNTech in Canada and the UPC over lipid nanoparticle patents, days after collecting $178 million from their Moderna settlement.
-
The CNIPA aligns China’s administrative SEP injunction standard with courts’ FRAND test
Read more: The CNIPA aligns China’s administrative SEP injunction standard with courts’ FRAND testThe CNIPA has made FRAND review a condition for administrative SEP cease-infringement orders, aligning the administrative approach with the judicial test. The clarification closes a gap in China’s dual-track patent enforcement system while CNIPA promotes greater use of administrative proceedings for SEP disputes.
-
UPC Roundup (1 week): CoA clarifies appellate procedure; Dusseldorf revokes inspection order; FRAND counterclaims head to appeal; and more
Read more: UPC Roundup (1 week): CoA clarifies appellate procedure; Dusseldorf revokes inspection order; FRAND counterclaims head to appeal; and moreThis is a summary of developments in and around the UPC in the calendar week of July 12, 2026.
-
Rio de Janeiro Court of Appeal unanimously upholds Panasonic’s AAC patent injunction against HMD, rejects bilateral licensing demand
Read more: Rio de Janeiro Court of Appeal unanimously upholds Panasonic’s AAC patent injunction against HMD, rejects bilateral licensing demandBrazil’s Rio de Janeiro Court of Appeals has unanimously upheld a preliminary injunction Panasonic won against HMD over an AAC patent, rejecting the claim that FRAND requires a separate bilateral licensing offer.
Follow Us
Latest Articles
- Malikie Innovations sets sights on medical device segment with latest U.S. complaint targeting Abbott
- 14 years of litigation, 28 days of breakthroughs: Apple contains a once-€1.2 billion Siri patent threat and advances its China AI rollout
- USPTO Director Squires to deliver keynote speech at Via Licensing Alliance’s marquee Bridge Summit this October
- UPC Court of Appeal establishes framework for conditional revocation counterclaims
- District Judge preserves Masimo’s $634M jury verdict against Apple; Federal Circuit denies rehearing request over their USITC case